HCWB
HCW Biologics Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.87
+0.00%Margins
Gross margin
95.9%
EBITDA margin
-63.6%
EBIT margin
-91.6%
Net margin
-73.2%
FCF margin
-180.6%
-66.3%
Return on equity
-18.4%
Return on assets
-44.0%
Return on invested capital
0.25x
Asset turnover
-$12.1M
Cash from operations
$0.40
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026